| Robert D Osborn, LCSW | |
|
1421 Burning Tree Rd, Henrico, VA 23231-6804 | |
| (804) 218-4382 | |
| (804) 486-5290 |
| Full Name | Robert D Osborn |
|---|---|
| Gender | Male |
| Speciality | Clinical Social Worker |
| Experience | 36 Years |
| Location | 1421 Burning Tree Rd, Henrico, Virginia |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124077201 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 0904002096 (Virginia) | Primary |
| Entity Name | Robert Osborn, Lcsw, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568160307 PECOS PAC ID: 2668839101 Enrollment ID: O20230527000083 |
News Archive
Researchers at the University of Pittsburgh School of Medicine have learned that some healthy people naturally developed an immune response against a protein that is made in excess levels in many cancers, including breast, lung, and head and neck cancers. The finding suggests that a vaccine against the protein might prevent malignancies in high-risk individuals.
The death rate among patients prescribed a statin in a major trial that ended in 2003 is still lower than those given a placebo, even though most participants in both groups have been taking statins ever since. ASCOT, the Anglo-Scandinavian Cardiac Outcomes Trial, was stopped early because the statin was so effective at preventing heart attacks and strokes, but a new analysis has shown that eight years on, the most significant difference between the groups is a reduction in deaths from infection and respiratory illness.
The patent which is assigned to the University of Pittsburgh has been exclusively licensed to PRP. The drug, known as PulmoLAR, containing 2ME as active ingredient, is currently developed by PRP for the treatment of pulmonary arterial hypertension (PAH).
The results of an interventional trial presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that use of the disease-modifying anti-rheumatic drug hydroxychloroquine for 24 weeks did not diminish mild-moderate pain from primary hand osteoarthritis (OA).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert D Osborn, LCSW 1421 Burning Tree Rd, Henrico, VA 23231-6804 Ph: (804) 218-4382 | Robert D Osborn, LCSW 1421 Burning Tree Rd, Henrico, VA 23231-6804 Ph: (804) 218-4382 |
News Archive
Researchers at the University of Pittsburgh School of Medicine have learned that some healthy people naturally developed an immune response against a protein that is made in excess levels in many cancers, including breast, lung, and head and neck cancers. The finding suggests that a vaccine against the protein might prevent malignancies in high-risk individuals.
The death rate among patients prescribed a statin in a major trial that ended in 2003 is still lower than those given a placebo, even though most participants in both groups have been taking statins ever since. ASCOT, the Anglo-Scandinavian Cardiac Outcomes Trial, was stopped early because the statin was so effective at preventing heart attacks and strokes, but a new analysis has shown that eight years on, the most significant difference between the groups is a reduction in deaths from infection and respiratory illness.
The patent which is assigned to the University of Pittsburgh has been exclusively licensed to PRP. The drug, known as PulmoLAR, containing 2ME as active ingredient, is currently developed by PRP for the treatment of pulmonary arterial hypertension (PAH).
The results of an interventional trial presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that use of the disease-modifying anti-rheumatic drug hydroxychloroquine for 24 weeks did not diminish mild-moderate pain from primary hand osteoarthritis (OA).
› Verified 5 days ago
Priscilla Helen Witwer, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 4825 S Laburnum Ave, Henrico, VA 23231 Phone: 804-727-8100 Fax: 804-727-8580 | |
Priscilla Lee Herzberg, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12093-95 Gayton Rd, Henrico, VA 23238 Phone: 804-205-3408 Fax: 617-807-0958 | |
Brian Michael Mayer, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9601 Gayton Rd, Henrico, VA 23238 Phone: 804-464-8250 | |
Jennifer Anne Walker, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2800 N Parham Rd Ste 210, Henrico, VA 23294 Phone: 804-263-7425 | |
Aaron Rowe, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3111 Northside Ave Ste 101, Henrico, VA 23228 Phone: 804-386-3246 | |
Diana Leigh Embler, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2606 Maplewood Rd, Henrico, VA 23228 Phone: 207-272-2996 Fax: 804-409-7583 |